Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ESLA Estrella Immunopharma

盘前交易 03-19 08:09:25 EDT

1.08

-0.03

-2.70%

最高1.19	最低1.08	成交量9.89万
今开1.10	昨收1.11	日振幅9.91%
总市值4,540万	流通市值1,878万	总股本4,203万
成交额11.13万	换手率0.57%	流通股本1,739万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":1.08,"timestamp":1773864000000,"preClose":1.11,"halted":0,"volume":98883,"delay":0,"changeRate":-0.02702702702702705,"floatShares":17391600,"shares":42034200,"eps":-0.367652,"marketStatus":"盘前交易","change":-0.03,"latestTime":"03-19 08:09:25 EDT","open":1.1,"high":1.19,"low":1.08,"amount":111270.676596,"amplitude":0.099099,"askPrice":1.46,"askSize":100,"bidPrice":0.9511,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.367652,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773927000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":1.08,"postHourTrading":{"tag":"盘后","latestPrice":1.08,"preClose":1.08,"latestTime":"16:40 EDT","volume":13,"amount":14.14,"timestamp":1773866426557,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.9909750367089236},"requestUrl":"/m/hq/s/ESLA","defaultTab":"news","newsList":[{"id":"2618956961","title":"Estrella Immunopharma, Inc.盘中异动 早盘急速拉升6.54%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618956961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618956961?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:57","pubTimestamp":1773068262,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日22时57分，Estrella Immunopharma, Inc.股票出现异动，股价快速拉升6.54%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，An2 Therapeutics, Inc.、Xenon制药、Relmada Therapeutics, Inc.涨幅较大，Relmada Therapeutics, Inc.、An2 Therapeutics, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为39.77%、29.36%、25.45%，振幅较大的相关个股有An2 Therapeutics, Inc.、Aditxt, Inc.、Polaryx Therapeutics, Inc.，振幅分别为47.72%、37.17%、35.76%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603092257429546273c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603092257429546273c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2617859521","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨7.17%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617859521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617859521?lang=zh_cn&edition=full","pubTime":"2026-03-04 23:28","pubTimestamp":1772638100,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日23时28分，Estrella Immunopharma, Inc.股票出现异动，股价大幅上涨7.17%。截至发稿，该股报1.17美元/股，成交量1557股，换手率0.00%，振幅1.83%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304232820954303d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304232820954303d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2613724568","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速跳水5.69%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613724568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613724568?lang=zh_cn&edition=full","pubTime":"2026-02-21 00:12","pubTimestamp":1771603946,"startTime":"0","endTime":"0","summary":"北京时间2026年02月21日00时12分，Estrella Immunopharma, Inc.股票出现异动，股价大幅下挫5.69%。截至发稿，该股报1.16美元/股，成交量1.526万股，换手率0.04%，振幅3.24%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。Estrella 的使命是利用人类免疫系统的进化力量来改变癌症和自身免疫性疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602210012279541898c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602210012279541898c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"1102194995","title":"Estrella Immunopharma完成800万美元注册直接发行与同步私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1102194995","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102194995?lang=zh_cn&edition=full","pubTime":"2026-01-07 03:02","pubTimestamp":1767726148,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma（股票代码：ESLA）宣布成功完成800万美元的注册直接发行及同步进行的私募配售。此次融资将用于推进公司核心免疫疗法管线的临床开发，增强企业资本结构。通过结合公开市场发行与私募融资的双轨策略，公司展现了在复杂市场环境中灵活获取资本的执行能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA","ESLAW"],"gpt_icon":0},{"id":"2601869472","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨5.06%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601869472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601869472?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:33","pubTimestamp":1767623580,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日22时33分，Estrella Immunopharma, Inc.股票出现异动，股价急速上涨5.06%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105223301953c03ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105223301953c03ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"1141368458","title":"Estrella Immunopharma公司宣布800万美元注册直接发行及同步私募配售，按纳斯达克规则以市价定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1141368458","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141368458?lang=zh_cn&edition=full","pubTime":"2026-01-05 21:30","pubTimestamp":1767619823,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma公司已正式披露一项融资计划，将实施总额800万美元的注册直接发行，并同步开展私募配售。此次发行的定价将严格遵循纳斯达克市场规则，采用市价定价机制。该举措旨在为公司的免疫药物研发及业务拓展注入新的资金动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2594094264","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨6.58%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594094264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594094264?lang=zh_cn&edition=full","pubTime":"2025-12-25 01:23","pubTimestamp":1766596990,"startTime":"0","endTime":"0","summary":"北京时间2025年12月25日01时23分，Estrella Immunopharma, Inc.股票出现异动，股价急速拉升6.58%。截至发稿，该股报1.62美元/股，成交量6300股，换手率0.02%，振幅4.61%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122501231097a0a771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122501231097a0a771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"1113157198","title":"Estrella Immunopharma - 提供高达2,541,206股的转售机会给售股股东 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1113157198","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113157198?lang=zh_cn&edition=full","pubTime":"2025-12-22 23:58","pubTimestamp":1766419092,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma - 提供高达2,541,206股的转售机会给售股股东 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2588032226","title":"Estrella Immunopharma, Inc.盘中异动 早盘大幅跳水5.21%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588032226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588032226?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:51","pubTimestamp":1764600673,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日22时51分，Estrella Immunopharma, Inc.股票出现波动，股价急速下跌5.21%。截至发稿，该股报2.00美元/股，成交量2.5864万股，换手率0.07%，振幅9.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201225113a71d2844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201225113a71d2844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2586129096","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速上涨6.93%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586129096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586129096?lang=zh_cn&edition=full","pubTime":"2025-11-26 22:34","pubTimestamp":1764167682,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日22时34分，Estrella Immunopharma, Inc.股票出现波动，股价急速上涨6.93%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Scisparc Ltd.、Quantum Biopharma Ltd.涨幅较大，Scisparc Ltd.、Kala Bio, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为1809.05%、154.82%、41.09%，振幅较大的相关个股有Quantum Biopharma Ltd.、Pasithea Therapeutics Corp.、Scisparc Ltd.，振幅分别为20.40%、10.89%、9.45%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126223442951bd857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126223442951bd857&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2586781304","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨5.26%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586781304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586781304?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:52","pubTimestamp":1763999523,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时52分，Estrella Immunopharma, Inc.股票出现异动，股价快速上涨5.26%。截至发稿，该股报1.60美元/股，成交量2.171万股，换手率0.06%，振幅4.61%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124235203a70ea86a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124235203a70ea86a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2585711371","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨5.43%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585711371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585711371?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:36","pubTimestamp":1763649413,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日22时36分，Estrella Immunopharma, Inc.股票出现波动，股价急速拉升5.43%。截至发稿，该股报1.85美元/股，成交量9935股，换手率0.03%，振幅3.43%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120223653a4af7c96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120223653a4af7c96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2584963539","title":"Estrella Immunopharma, Inc.盘中异动 快速跳水6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584963539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584963539?lang=zh_cn&edition=full","pubTime":"2025-11-19 01:30","pubTimestamp":1763487003,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日01时30分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌6.18%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111901300397719f9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111901300397719f9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2581064165","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨7.15%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581064165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581064165?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:38","pubTimestamp":1762353485,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日22时38分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨7.15%。截至发稿，该股报2.45美元/股，成交量3.9399万股，换手率0.11%，振幅5.68%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511052238059755fcda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511052238059755fcda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"1164382933","title":"Estrella Immunopharma 完成剂量组后，DSMB将审查研究数据的安全性和有效性","url":"https://stock-news.laohu8.com/highlight/detail?id=1164382933","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164382933?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:10","pubTimestamp":1762175410,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma 完成剂量组后，DSMB将审查研究数据的安全性和有效性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"1155605883","title":"Estrella Immunopharma在Starlight-1试验中完成第二剂量组的评估，所有可评估患者均获得完全缓解","url":"https://stock-news.laohu8.com/highlight/detail?id=1155605883","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155605883?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:01","pubTimestamp":1762174878,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma在Starlight-1试验中完成第二剂量组的评估，所有可评估患者均获得完全缓解","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2572604405","title":"Estrella Immunopharma, Inc.盘中异动 急速拉升6.83%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572604405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572604405?lang=zh_cn&edition=full","pubTime":"2025-10-01 21:32","pubTimestamp":1759325538,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日21时32分，Estrella Immunopharma, Inc.股票出现波动，股价急速拉升6.83%。截至发稿，该股报1.23美元/股，成交量230股，换手率0.00%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001213218a4502d8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001213218a4502d8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2570866901","title":"Estrella Immunopharma, Inc.盘中异动 临近收盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570866901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570866901?lang=zh_cn&edition=full","pubTime":"2025-09-27 03:48","pubTimestamp":1758916115,"startTime":"0","endTime":"0","summary":"北京时间2025年09月27日03时48分，Estrella Immunopharma, Inc.股票出现异动，股价快速拉升5.22%。截至发稿，该股报1.21美元/股，成交量9.4518万股，换手率0.26%，振幅5.22%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927034835a446a484&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927034835a446a484&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2569332067","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨7.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569332067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569332067?lang=zh_cn&edition=full","pubTime":"2025-09-22 21:37","pubTimestamp":1758548220,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日21时37分，Estrella Immunopharma, Inc.股票出现波动，股价大幅上涨7.21%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Metsera, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2271.51%、122.97%、38.26%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Onconetix, Inc.、Adverum Biotechnologies, Inc.，振幅分别为68.66%、22.86%、19.53%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922213700a72f87b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922213700a72f87b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2518720833","title":"Estrella Immunopharma, Inc.盘中异动 大幅跳水8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518720833?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:22","pubTimestamp":1741623768,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时22分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌8.84%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3707.85%、3218.00%、951.39%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002248964058fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002248964058fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.estrellabio.com","stockEarnings":[{"period":"1week","weight":-0.1148},{"period":"1month","weight":-0.1462},{"period":"3month","weight":-0.3165},{"period":"6month","weight":-0.027},{"period":"1year","weight":0.1868},{"period":"ytd","weight":-0.3077}],"compareEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":-0.0298},{"period":"3month","weight":-0.0222},{"period":"6month","weight":-0.0034},{"period":"1year","weight":0.179},{"period":"ytd","weight":-0.03}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Estrella Immunopharma, Inc.于2021年1月6日在特拉华州注册成立。该公司是一家临床前阶段的生物制药公司，开发CD19和CD22靶向ARTEMIS T细胞疗法，有能力应对血癌和实体瘤患者的治疗挑战。该公司的使命是利用人类免疫系统的进化力量，改变癌症患者的生活。为了完成这一使命，该公司的主要候选产品EB103利用Eureka的ARTEMIS技术来靶向CD19，一种在几乎所有B细胞白血病和淋巴瘤表面表达的蛋白质。该公司也在开发EB104，它还利用Eureka的ARTEMIS技术，不仅针对CD19，还针对CD22，一种与CD19一样在大多数B细胞恶性肿瘤表面表达的蛋白质。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.071617},{"month":2,"riseRate":0.6,"avgChangeRate":-0.002484},{"month":3,"riseRate":0.4,"avgChangeRate":-0.001805},{"month":4,"riseRate":0.75,"avgChangeRate":0.006035},{"month":5,"riseRate":0.25,"avgChangeRate":-0.040145},{"month":6,"riseRate":0.5,"avgChangeRate":0.017516},{"month":7,"riseRate":0.5,"avgChangeRate":0.07367},{"month":8,"riseRate":0.25,"avgChangeRate":-0.054345},{"month":9,"riseRate":0.75,"avgChangeRate":0.07408},{"month":10,"riseRate":0.6,"avgChangeRate":-0.005756},{"month":11,"riseRate":0.8,"avgChangeRate":0.071826},{"month":12,"riseRate":0.2,"avgChangeRate":-0.109506}],"exchange":"NASDAQ","name":"Estrella Immunopharma","nameEN":"Estrella Immunopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Estrella Immunopharma,ESLA,Estrella Immunopharma股票,Estrella Immunopharma股票老虎,Estrella Immunopharma股票老虎国际,Estrella Immunopharma行情,Estrella Immunopharma股票行情,Estrella Immunopharma股价,Estrella Immunopharma股市,Estrella Immunopharma股票价格,Estrella Immunopharma股票交易,Estrella Immunopharma股票购买,Estrella Immunopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}